Literature DB >> 18093537

Human primary immunodeficiency diseases.

Alain Fischer1.   

Abstract

Primary immunodeficiency diseases (PID) provide invaluable insight into immune system, notably in vivo immune responses to microorganisms as based on the variable vulnerability to pathogens and opportunistic agents. PID are also very informative in defining key checkpoints controlling immunity to self. Despite a Mendelian inheritance of most PID, mutations of a given gene can lead to a vast array of phenotypes as a function of the type of mutations, environmental factors, the occurrence of additional somatic mutations, or regulatory factors, which add considerable but hitherto underestimated complexity. Understanding the molecular pathophysiology of PID is not only contributing to a better knowledge of the immune system but may also favor new therapeutic approaches.

Entities:  

Mesh:

Year:  2007        PMID: 18093537     DOI: 10.1016/j.immuni.2007.11.012

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  47 in total

1.  Beyond pattern recognition: five immune checkpoints for scaling the microbial threat.

Authors:  J Magarian Blander; Leif E Sander
Journal:  Nat Rev Immunol       Date:  2012-02-24       Impact factor: 53.106

Review 2.  Neutrophil apoptosis: relevance to the innate immune response and inflammatory disease.

Authors:  Sarah Fox; Andrew E Leitch; Rodger Duffin; Christopher Haslett; Adriano G Rossi
Journal:  J Innate Immun       Date:  2010-02-11       Impact factor: 7.349

3.  LPS-responsive beige-like anchor (LRBA) gene mutation in a family with inflammatory bowel disease and combined immunodeficiency.

Authors:  Abdullah Alangari; Abdulrahman Alsultan; Nouran Adly; Michel J Massaad; Iram Shakir Kiani; Abdulrahman Aljebreen; Emad Raddaoui; Abdul-Kareem Almomen; Saleh Al-Muhsen; Raif S Geha; Fowzan S Alkuraya
Journal:  J Allergy Clin Immunol       Date:  2012-06-19       Impact factor: 10.793

Review 4.  Forward genetic dissection of innate response to infection in inbred mouse strains: selected success stories.

Authors:  S Gruenheid; P Gros
Journal:  Clin Exp Immunol       Date:  2010-12       Impact factor: 4.330

5.  Immune reconstitution after HSCT in SCID-a cohort of conditioned and unconditioned patients.

Authors:  Uri Manor; Atar Lev; Amos J Simon; Daphna Hutt; Amos Toren; Bella Bielorai; Lior Goldberg; Tali Stauber; Raz Somech
Journal:  Immunol Res       Date:  2019-06       Impact factor: 2.829

Review 6.  Inborn errors in immunity: unique natural models to dissect oral immunity.

Authors:  N M Moutsopoulos; M S Lionakis; G Hajishengallis
Journal:  J Dent Res       Date:  2015-04-21       Impact factor: 6.116

Review 7.  Primary immunodeficiencies reveal the essential role of tissue neutrophils in periodontitis.

Authors:  Lakmali M Silva; Laurie Brenchley; Niki M Moutsopoulos
Journal:  Immunol Rev       Date:  2019-01       Impact factor: 12.988

8.  ORAI1 deficiency and lack of store-operated Ca2+ entry cause immunodeficiency, myopathy, and ectodermal dysplasia.

Authors:  Christie-Ann McCarl; Capucine Picard; Sara Khalil; Takumi Kawasaki; Jens Röther; Alexander Papolos; Jeffery Kutok; Claire Hivroz; Francoise Ledeist; Katrin Plogmann; Stephan Ehl; Gundula Notheis; Michael H Albert; Bernd H Belohradsky; Janbernd Kirschner; Anjana Rao; Alain Fischer; Stefan Feske
Journal:  J Allergy Clin Immunol       Date:  2009-12       Impact factor: 10.793

9.  Combined immunodeficiency associated with DOCK8 mutations.

Authors:  Qian Zhang; Jeremiah C Davis; Ian T Lamborn; Alexandra F Freeman; Huie Jing; Amanda J Favreau; Helen F Matthews; Joie Davis; Maria L Turner; Gulbu Uzel; Steven M Holland; Helen C Su
Journal:  N Engl J Med       Date:  2009-09-23       Impact factor: 91.245

10.  The actin regulator coronin 1A is mutant in a thymic egress-deficient mouse strain and in a patient with severe combined immunodeficiency.

Authors:  Lawrence R Shiow; David W Roadcap; Kenneth Paris; Susan R Watson; Irina L Grigorova; Tonya Lebet; Jinping An; Ying Xu; Craig N Jenne; Niko Föger; Ricardo U Sorensen; Christopher C Goodnow; James E Bear; Jennifer M Puck; Jason G Cyster
Journal:  Nat Immunol       Date:  2008-10-05       Impact factor: 25.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.